Funder
Biotechnology and Biological Sciences Research Council
Wellcome Trust
Medical Research Council
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Kintzing JR, Filsinger Interrante MV, Cochran JR. Emerging strategies for developing next-generation protein therapeutics for cancer treatment. Trends Pharmacol Sci. 2016;37:993–1008.
2. Pavlou AK, Reichert JM. Recombinant protein therapeutics--success rates, market trends and values to 2010. Nat Biotechnol. 2004;22:1513–9.
3. Lagassé HAD, Alexaki A, Simhadri VL, Katagiri NH, Jankowski W, Sauna ZE, et al. Recent advances in (therapeutic protein) drug development. F1000Res. 2017;6:113.
https://doi.org/10.12688/f1000research.9970.1
.
4. Mauro VP. Codon optimization in the production of recombinant biotherapeutics: potential risks and considerations. BioDrugs. 2018;32:69–81.
5. National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Care Services, Committee on Ensuring Patient Access to Affordable Drug Therapies. Making medicines affordable: a national imperative. Washington (DC): National Academies Press (US); 2017.
http://www.ncbi.nlm.nih.gov/books/NBK493094/
. Accessed 11 Apr 2018
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献